Vaccine Weekly articles from September 2000

Vaccine Weekly archives from September 2000

Human Parainfluenza Virus Type 3 Used to Make Vaccine.(against measles)(Brief Article)
September 6, 2000... 2000 SEP 6 - (NewsRx.com) -- A mucosal vaccine has been developed to immunize infants against measles and human parainfluenza virus. "Recombinant human parainfluenza virus type 3 (PIV3) was used as a vector to express the major...

HIV-1 Specific Immune Responses Generated by Vaccine and Booster.(Brief Article)
September 6, 2000... 2000 SEP 6 - (NewsRx.com) -- Researchers in the United States have evaluated immune responses in HIV-1 seronegative volunteers immunized with a recombinant canarypox and gp120 prime-boost HIV-1 vaccine. University of Alabama...

Combined Antibody/Antivascular Therapy Eradicates Tumors in Mouse Model.(Brief Article)
September 6, 2000... 2000 SEP 6 - (NewsRx.com) -- Promising results from preclinical studies with an antitumor protocol that combined antibody and antivascular therapy have spurred Phase I clinical trials, researchers in the United Kingdom reported. ...

Immediate Response to Skin Test is Good Predictor of Anaphylaxis.(adverse reaction to pneumococcal vaccine in children)(Brief Article)
September 6, 2000... 2000 SEP 6 - (NewsRx.com) -- Researchers in France determined that immediate response to skin tests is a good predictor of an anaphylactic reaction to pneumococcal vaccine in children. "Pneumococcal vaccines are usually...

Booster Doses of Hepatitis A Vaccine Effective Even When Given 56 Months Apart.(Brief Article)
September 6, 2000... 2000 SEP 6 - (NewsRx.com) -- Researchers in Switzerland have shown that two doses of a virosome-formulated hepatitis A virus (HAV) vaccine were still effective even if the doses were administered 18 to 56 months apart. "In order to...

Pseudothrombocytopenia in Abciximab Therapy Examined.(Brief Article)
September 6, 2000... 2000 SEP 6 - (NewsRx.com) -- Researchers in the United States suggest that the onset of pseudothrombocytopenia as a result of Abciximab therapy should not discourage clinicians from continuing therapy. "This study determined the...

Experts Say Shots Should Be Used More Frequently in Allergic Asthma to Prevent Disease.(Brief Article)
September 6, 2000... 2000 SEP 6 - (NewsRx.com) -- Patients who are diagnosed with allergic asthma, or with allergies such as hay fever or sinusitis that predispose them to asthma, should strongly consider allergy shots to prevent the development of new or...

Ohio State to Host First Worldwide Biomed/Nanotech Meeting.(Brief Article)
September 6, 2000... 2000 SEP 6 - (NewsRx.com) -- Hundreds of researchers are expected in September 2000 at Ohio State University, Columbus, for the first-ever comprehensive international conference devoted to two growing disciplines that may revolutionize...

Vaccine Approved for Phase II Study.(Diamyd diabetes vaccine to be tested)(Brief Article)
September 6, 2000... 2000 SEP 6 - (NewsRx.com) -- Diamyd Medical AB, (DIAMb.epfn; Diam b SS), Stockholm, Sweden, announced that regulatory authorities in Sweden have approved the company's application to conduct a Phase II study with its diabetes vaccine...

Collaboration Announced to Develop Antibody Therapeutics.(between Medarex Inc. and Atherysis Inc.)(Brief Article)
September 6, 2000... 2000 SEP 6 - (NewsRx.com) -- Medarex, Inc. (MEDX), Princeton, New Jersey, and Athersys, Inc., Cleveland, Ohio, announced a collaboration to develop therapeutics produced through the joint application of Medarex's HuMAb-Mouse technology...

U.S. Navy to Fund Phase III Trial of Campylobacter Vaccine.(has signed research agreement with Antex Biologics Inc.)(Brief Article)
September 6, 2000... 2000 SEP 6 - (NewsRx.com) -- Antex Biologics Inc. (ATXB), Gaithersburg, Maryland, announced that it has signed a Cooperative Research and Development Agreement (CRADA) with the U.S. Department of the Navy whereby the Navy will continue...

Discovery in Proprietary DNA Delivery System Announced.(Brief Article)
September 6, 2000... 2000 SEP 6 - (NewsRx.com) -- Supratek Pharma, Montreal, Quebec, Canada, announced at the American Chemical Society Annual Conference (ACS) that SP1017, its non-viral gene delivery system, significantly increases gene expression in muscle,...

Antibody Therapy Highly Potent in Murine Model.(Brief Article)
September 6, 2000... 2000 SEP 6 - (NewsRx.com) -- Researchers in Germany have created an antibody-based immunotherapy that produces promising results in animal cancer models. "The use of anti-CD3xantitumor bispecific Abs [antibodies] is an attractive and...

Immunotoxin Targets Mesothelin, Effective in Animal Models.(Brief Article)
September 6, 2000... 2000 SEP 6 - (NewsRx.com) -- Immunotoxins targeting mesothelin may have therapeutic potential against ovarian cancer and malignant mesotheliomas. Researchers in the United States evaluated the anti-tumor activity of the immunotoxin...

Researchers Say Shots Often Overused.(rabies shots overused)(Brief Article)
September 6, 2000... 2000 SEP 6 - (NewsRx.com) -- Rabies shots are often overused in treating people bitten by animals, researchers report. About 40,000 shots are given annually in the United States, and a recent study suggests they may be unnecessary in...

Patent License Received on Oral Vaccine.(Avant Immunotherapeutics Inc. receives patent for Ty800 typhoid vaccine)(Brief Article)
September 6, 2000... 2000 SEP 6 - (NewsRx.com) -- Avant Immunotherapeutics, Inc. (AVAN), Needham, Massachusetts, announced the signing of a cross-licensing agreement with Megan Health Inc. for exclusive rights to a patent portfolio supportive of Avant's...

Approval Advised to Conduct Australian Treatment Trial.(Virax Holdings Ltd.)(Brief Article)
September 13, 2000... 2000 SEP 13 - (NewsRx.com) -- Virax Holdings Limited (VHL), Melbourne, Australia, announced that Australia's Therapeutic Goods Administration (TGA) has advised approval of the company's Clinical Trials Exemption (CTX) application to...

DNA Immunization Produces Anti-Major Histocompatibility Complex Antibody Responses.(Brief Article)
September 13, 2000... 2000 SEP 13 - (NewsRx.com) -- DNA immunization with major histocompatibility complex (MHC)-encoding vectors induced specific immune responses in macaque model of HIV, researchers in Canada reported. "In simian immunodeficiency virus...

Immunity Induced by Protein Conjugated to Immunostimulatory DNA.(Brief Article)
September 13, 2000... 2000 SEP 13 - (NewsRx.com) -- Protein conjugated to immunostimulatory DNA resulted in cell-mediated and humoral immunity against HIV, reported researchers in the United States. "Immunostimulatory DNA sequences (ISS) are a potent Th1...

Phase I Clinical Trial Data Reported.(American Society of Clinical Oncology)(Brief Article)
September 13, 2000... 2000 SEP 13 - (NewsRx.com) -- Data from a Phase I clinical trial of the therapeutic cancer vaccine based on B7-1 (H5.030CMVHB7) were reported at the 36th Annual Meeting of the American Society of Clinical Oncology, held in New Orleans,...

New Bacillus Calmette-Guerin-Based Vaccines Under Development.(Brief Article)
September 13, 2000... 2000 SEP 13 - (NewsRx.com) -- Researchers in the United Kingdom evaluated a new generation of vaccines against Mycobacterium tuberculosis (TB) based on bacillus Calmette-Guerin (BCG) auxotrophic mutants in an animal model. "Despite...

Heart Drug Proves Disappointing.(abciximab)(Brief Article)
September 13, 2000... 2000 SEP 13 - (NewsRx.com) -- A clot-blocking drug that doctors thought would help stabilize people immediately after a near-heart attack and reduce their chances of dying or having a heart attack is a disappointment, new research shows....

Chimeric Anti-Ganglioside GD3 Antibody KM871 Has Therapeutic Potential.(Brief Article)
September 13, 2000... 2000 SEP 13 - (NewsRx.com) -- Researchers in Japan have found that the chimeric anti-ganglioside GD3 antibody, KM871, has anticancer therapeutic potential. "KM871 is a chimeric antibody recognizing ganglioside GD3, which is one of the...

First Potential 'Universal' Vaccine Shows Promise in Lab.(cancer vaccine)(Brief Article)
September 13, 2000... 2000 SEP 13 - (NewsRx.com) -- Results from preliminary laboratory studies provide the first functional evidence that developing a "universal" cancer vaccine might be possible, researchers from Duke University Medical Center and Geron...

Meta-Analysis Indicates Vaccine Extends Recurrence-Free Survival in Stage II Disease.(OncoVAX)(Brief Article)
September 13, 2000... 2000 SEP 13 - (NewsRx.com) -- Intracel Corp., Rockville, Maryland, reported the findings of a meta-analysis of three clinical trials that demonstrated its autologous tumor cell vaccine, OncoVAX, significantly improves the recurrence-free...

Terms Agreement Established for Prophylactic Vaccine.(Brief Article)
September 13, 2000... 2000 SEP 13 - (NewsRx.com) -- Cantab Pharmaceuticals plc (CNTBY) (CTB), Cambridge, United Kingdom, announced that it has reached final agreement with Glaxo Wellcome plc on the terms for the return to Cantab of the rights to the DISC HSV...

Aetna U.S. Healthcare of California Pays Physicians for Vaccines.(Brief Article)
September 13, 2000... 2000 SEP 13 - (NewsRx.com) -- Aetna U.S. Healthcare of California announced it will pay doctors the cost of any new vaccines recommended by the American Academy of Pediatrics (AAP) and the Advisory Committee on Immunization Practices...

Monoclonal Antibody + Immunosuppressant Safety Data Presented.(BioTransplant Inc. and Liver Transplant Program at St. Luc University Hospital in Brussels)(Brief Article)
September 13, 2000... 2000 SEP 13 - (NewsRx.com) -- BioTransplant Inc. (BTRN), Charlestown, Massachusetts, and its collaborators from the Liver Transplant Program at St. Luc University Hospital in Brussels, Belgium, announced the results of a Phase I/II study...

Gates Foundation Awards $40 Million for Research.(Bill and Melinda Gates Foundation awards grant to Johns Hopkins University)(Brief Article)
September 13, 2000... 2000 SEP 13 - (NewsRx.com) -- The Bill and Melinda Gates Foundation awarded US$40 million August 28, 2000, to Johns Hopkins University, Baltimore, Maryland, and the University of Maryland for development of a new measles vaccine that...

Preliminary Data Show Immunogene Therapy is Safe.(Brief Article)
September 13, 2000... 2000 SEP 13 - (NewsRx.com) -- Preliminary data from an ongoing Phase I clinical trial of immunogene therapy in melanoma patients suggest that the procedure is feasible and safe. "Dendritic cells (DCs) are potent antigen-presenting...

Pilot Trial Combines Chemotherapy/Rituximab for HIV Associated Disease.(Brief Article)
September 13, 2000... 2000 SEP 13 - (NewsRx.com) -- Researchers in Italy and the United States tested cyclophosphamide, doxorubicin, and etoposide (CDE) combined with the anti-CD20 monoclonal antibody (MAb) rituximab in patients with HIV associated...

Radioimmunotherapy Produces Promising Results in Clinical Trial.(Brief Article)
September 13, 2000... 2000 SEP 13 - (NewsRx.com) -- Radioimmunotherapy with 90y-labeled humanized LL2 (90Y-hLL2) anti-CD22 monoclonal antibody (MAb) has produced encouraging anti-tumor responses in refractory non-Hodgkin's lymphoma (NHL). Stephen L....

FDA Approves Expansion of Tripedia Use in DTP Immunization Series.(Aventis Pasteur Inc.)(Brief Article)
September 13, 2000... 2000 SEP 13 - (NewsRx.com) -- Aventis Pasteur Inc., Swiftwater, Pennsylvania, said that it received U.S. Food and Drug Administration (FDA) approval to market Tripedia (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine...

Abciximab Improves Clinical Course.(of thrombocytopenia)(Brief Article)
September 13, 2000... 2000 SEP 13 - (NewsRx.com) -- According to a study from the United States, abciximab prophylaxis improved the clinical course of thrombocytopenia occurring after percutaneous coronary interventions. "Thrombocytopenia is infrequently...

WHO Reports Epidemic Widening in Liberia.(World Health Organization)(Brief Article)
September 13, 2000... 2000 SEP 13 - (NewsRx.com) -- A yellow fever epidemic is gathering pace in Liberia, with at least 79 suspected cases now detected, the World Health Organization said August 29, 2000. "As we suspected... the epidemic is spreading,"...

Mycobacterium tuberculosis Ag38 Gene Cooperates with Interleukin 12 Against Tumors.(Brief Article)
September 20, 2000... 2000 SEP 20 - (NewsRx.com) -- A novel anticancer immunotherapy approach combines bacteria and cytokines in a vaccine vehicle. "An approach to stimulating an immune response against tumors is to transduce tumor cells with bacterial...

Discontinuation Did Not Increase Risk of TB and Meningitis in China.(bacillus Calmette-Guerin vaccine discontinued)(Brief Article)
September 20, 2000... 2000 SEP 20 - (NewsRx.com) -- Discontinuation of the bacillus Calmette-Guerin (BCG) vaccine did not increase the incidence of tuberculosis (TB) and meningitis in the Shun-yi county of China, researchers in that country reported. "In...

SIV gag DNA-Vaccinated Monkeys Develop Protective Immune Responses.(simian immunodeficiency virus)(Brief Article)
September 20, 2000... 2000 SEP 20 - (NewsRx.com) -- Researchers in the United States report that rhesus monkeys vaccinated with a simian immunodeficiency virus (SIV) gag DNA vaccine developed protective immune responses. "The potential contribution of a...

DNA-Based Flu Vaccine Raises Protective Immunity; Could be Model for Other Antiviral Vaccines.(Brief Article)
September 20, 2000... 2000 SEP 20 - (NewsRx.com) -- Scientists at the Vaccine Research Center of Emory University, Atlanta, Georgia, have successfully engineered and tested a single-dose, DNA-based influenza vaccine in mice that could serve as a template for...

Cellular 'Vehicle' that Transports Pneumonia Discovered.(Brief Article)
September 20, 2000... 2000 SEP 20 - (NewsRx.com) -- Pneumococcal disease is the most prevalent invasive disease of children in terms of both deaths and life- threatening complications. One such pneumococcal disease, pneumonia, kills 3.7 million children...

Phase I Trial Targets Monoclonal Antibody to Prostate-Specific Membrane Antigen.(Brief Article)
September 20, 2000... 2000 SEP 20 - (NewsRx.com) -- Results from a Phase I clinical trial of a monoclonal antibody (MAb) targeting the extracellular domain of prostate specific membrane antigen (PSMAext) in patients with hormone-independent prostate cancer are...

Bacterial Protein Shows Promise for Cancer Vaccine.(Shiga B-subunit)(Brief Article)
September 20, 2000... 2000 SEP 20 - (NewsRx.com) -- A non-toxic form of a bacterial protein known as Shiga B-subunit, together with tumor-associated molecules, can stimulate the immune system of mice to attack cancer cells without the need for secondary...

DNA Therapeutic Vaccine Tested in Cornell Mouse Model.(Mycobacterium tuberculosis vaccine tested)(Brief Article)
September 20, 2000... 2000 SEP 20 - (NewsRx.com) -- A therapeutic DNA vaccine against Mycobacterium tuberculosis was effective in reducing reactivation of tuberculosis in the Cornell mouse model, researchers in the United Kingdom reported. "The standard...

U.S. Navy Begins Additional DNA Vaccine Trial.(Bioject Medical Technologies Inc.)(Brief Article)
September 20, 2000... 2000 SEP 20 - (NewsRx.com) -- Bioject Medical Technologies Inc. (BJCT), Portland, Oregon, announced that the U.S. Naval Medical Research Center has begun a clinical study of a DNA-based malaria vaccine. The DNA-based malaria vaccine...

Blood of Horseshoe Crabs a Medical Miracle.(Limulus Amebocyte Lysate substance detects contaminants in drugs and medical devices)(Brief Article)
September 20, 2000... 2000 SEP 20 - (NewsRx.com) -- In a small unmarked building on a back island road four miles off the coast of Virginia, the bleeding begins. Hundreds of strange, spiked creatures are pinned to plastic racks as lab technicians in white...

Clinical Trials of Immunization Against Clade A HIV-1 Virus Begin.(Brief Article)
September 20, 2000... 2000 SEP 20 - (NewsRx.com) -- Researchers began clinical trials August 31, 2000, with a vaccine targeted at an African strain of AIDS. The vaccine is the first specifically designed to combat the Clade A HIV-1 virus, the most...

Herpesvirus Vector Shows Promise in Research.(for HIV vaccine)(Brief Article)
September 20, 2000... 2000 SEP 20 - (NewsRx.com) -- Two Harvard Medical School researchers working toward an HIV vaccine are yielding promising results using a novel viral vector known for its longevity, according to a study in the September 2000 Journal of...

International Team Leads Accelerated Investigation of Immune-Related Genes.(human leukocyte antigen)(Brief Article)
September 20, 2000... 2000 SEP 20 - (NewsRx.com) -- A cluster of nearly 220 genes known as the human leukocyte antigen (HLA) gene complex holds clues to many unsolved medical questions: why do transplants sometimes fail despite close donor-recipient matches?...

Radioimmunotherapy with 131-I-3F8 Monoclonal Antibody Reaches Phase I Trial.(Brief Article)
September 20, 2000... 2000 SEP 20 - (NewsRx.com) -- Researchers in the United States presented promising preliminary results from a Phase I clinical trial of a radioimmunotherapy (RIT) procedure against GD2-positive leptomeningeal (LM) cancers using the...

Vaccination Program Produces 85% Fall in Cases.(meningitis C immunization program)(Brief Article)
September 20, 2000... 2000 SEP 20 - (NewsRx.com) -- New figures from the U.K.'s Public Health Laboratory Service show that the meningitis C immunization program continues to have a big impact on this extremely serious disease and has produced an 85% reduction...

Immunotherapy with Epratuzumab Demonstrates Clinical Efficacy.(non-Hodgkin's lymphoma treatment)(Brief Article)
September 20, 2000... 2000 SEP 20 - (NewsRx.com) -- Immunotherapy of non-Hodgkin's lymphoma (NHL) with epratuzumab, an anti-CD22 monoclonal antibody (MAb), has demonstrated excellent tolerability and clear clinical efficacy, according to recent study findings....

Vaccine Can Reduce Acute Episodes in Children.(otitis media vaccine)(Brief Article)
September 20, 2000... 2000 SEP 20 - (NewsRx.com) -- Decision Resources, Inc., Waltham, Massachusetts, announced the publication of a study titled "Otitis Media." Otitis media, defined as inflammation or infection of the middle ear, is one of the most...

Phase I SBIR Grant Received to Develop Lipid-Based Vaccines.(Aquila Biopharmaceuticals Inc.)(Brief Article)
September 20, 2000... 2000 SEP 20 - (NewsRx.com) -- Aquila Biopharmaceuticals, Inc. (AQLA), Framingham, Massachusetts, announced that it has been awarded a grant from the U.S. National Institutes of Health (NIH) to support the development of novel vaccines to...

Most Chickenpox Vaccine Complications Found to be Minor.(Brief Article)
September 20, 2000... 2000 SEP 20 - (NewsRx.com) -- The majority of adverse events associated with varicella vaccine, used to prevent chickenpox, are not serious, according to an article in the September 13, 2000, issue of The Journal of the American Medical...

Chickenpox Immunization Confirmed Effective in Adults.(Brief Article)
September 20, 2000... 2000 SEP 20 - (NewsRx.com) -- The chickenpox (varicella) vaccine is highly effective in protecting adults from serious disease, and immunization is recommended for all adults who have never had chickenpox, according to information...

Dendritic Cell Vaccine Evaluated in Advanced Melanoma Patients.
September 27, 2000... 2000 SEP 27 - (NewsRx.com) -- Researchers in Italy evaluated a vaccine protocol based on dendritic cells (DC) pulsed with heat shock protein (HSP) or lysate from autologous tumor in patients with advanced melanoma. "A vaccination...

Fertilization-Related Sperm Antigens Have Immunocontraceptive Potential.
September 27, 2000... 2000 SEP 27 - (NewsRx.com) -- Researchers at the Medical College of Ohio are working on development of an anti-sperm vaccine. "Vaccine(s) for contraception will provide an attractive alternative to contraception," wrote R.K. Naz and...

Vaccine May Protect Against Herpes - But Only in Women.
September 27, 2000... 2000 SEP 27 - (NewsRx.com) -- Researchers have made the first vaccine that protects against genital herpes. But there is a major catch: it works only in women and only if they have never had cold sores. The findings, reported on...

Daclizumab and Triple Maintenance Immunosuppression Reduces Organ Rejection.
September 27, 2000... 2000 SEP 27 - (NewsRx.com) -- According to data from a clinical trial in the United States, daclizumab and triple maintenance immunosuppression reduces the incidence of rejection in patients with kidney transplants. "Daclizumab (DAC)...

Initial Phase I/II Vaccine Trial Results Reported.
September 27, 2000... 2000 SEP 27 - (NewsRx.com) -- Cell Genesys, Inc. (CEGE), Foster City, California, announced an encouraging follow-up report on an initial clinical trial of Gvax lung cancer vaccine. The trial was conducted in patients with advanced...

Anti-Idiotype Antibody Vaccine Induces Immune Response in Patients.
September 27, 2000... 2000 SEP 27 - (NewsRx.com) -- Clinical trial results show that vaccination with an anti-idiotype (ID) antibody mimicking N-Glycolyl containing gangliosides induced immune responses in melanoma patients. "We initiated a clinical trial...

Clinical Trial Enrollment Complete for Vaccine.
September 27, 2000... 2000 SEP 27 - (NewsRx.com) -- Antex Biologics Inc. (ANX), Gaithersburg, Maryland, announced that enrollment has been completed for its dosage and formulation clinical trial of Helivax, an orally administered vaccine intended to prevent and...

Therapeutic Vaccine Enters Expanded Clinical Studies.
September 27, 2000... 2000 SEP 27 - (NewsRx.com) -- Therion Biologics Corp., Cambridge, Massachusetts, and the U.S. National Cancer Institute (NCI) have initiated two additional Phase II trials for Prostvac VF. Prostvac VF, a vaccine designed to stimulate...

Issuance of Two U.S. Patents on Vaccine Technology Announced.
September 27, 2000... 2000 SEP 27 - (NewsRx.com) -- Cel-Sci Corp. (CVM), Vienna, Virginia, announced the issuance of two U.S. patents expanding the patent protection related to Cel-Sci's Ligand Epitope Antigen Presentation System (LEAPS) vaccine technology....

NIH Awards $20 Million for HIV Vaccine and Therapy Research.
September 27, 2000... 2000 SEP 27 - (NewsRx.com) -- SRI International, a non-profit research institute headquartered in Menlo Park, California, announced on September 6, 2000, that the U.S. National Institute of Allergies and Infectious Diseases (NIAID) will...

Ganglioside Conjugated Vaccine is Safe and Effective.
September 27, 2000... 2000 SEP 27 - (NewsRx.com) -- Data from a Phase I clinical trial of a ganglioside conjugated cancer vaccine in breast cancer patients showed the vaccine to be safe and immunologically effective, researchers in Cuba and Argentina report....

No AIDS-Related Viruses or Chimpanzee DNA Found in 1950s-Era Polio Vaccine.
September 27, 2000... 2000 SEP 27 - (NewsRx.com) -- Tests performed by three independent laboratories on 1950s-era polio vaccine samples from The Wistar Institute, Philadelphia, Pennsylvania, failed to find any traces of SIV, HIV-1, or DNA indicating that...

Oral DNA Vaccine Induces Mucosal and Systemic Immune Responses.
September 27, 2000... 2000 SEP 27 - (NewsRx.com) -- Researchers in Japan, Poland, and the United States collaborated on designing an orally-delivered DNA vaccine that produces mucosal and systemic immune responses against HIV. Discussing their study at the...

Scientists Call for Moratorium.
September 27, 2000... 2000 SEP 27 - (NewsRx.com) -- The following was issued by the Chronic Illness Research Foundation: [helv] Scientists... called for a moratorium on all HIV vaccine research and clinical trials until the mechanism of AIDS is further...

Combination Immunogene Therapy/Radiation Zaps Brain Metastases.
September 27, 2000... 2000 SEP 27 - (NewsRx.com) -- Researchers in Poland find that a combination of immunogene therapy and radiation is well tolerated and relieves symptoms in melanoma patients with brain metastases. Sergiusz Nawrocki and colleagues at...

Specific Immunotherapy Uses Attenuated Autologous Tumor Cells.
September 27, 2000... 2000 SEP 27 - (NewsRx.com) -- Active specific immunotherapy based on attenuated autologous tumor cells shows some responsiveness in patients with advanced stage melanoma, researchers in Brazil report. "From April 1998 to November...

Study Finds Booster Plus Oral Vaccine is Best Protection.(polio vaccine )
September 27, 2000... 2000 SEP 27 - (NewsRx.com) -- Giving a booster shot in addition to the oral polio vaccine is the best way to ensure that babies in Third World countries are protected from the virus, a study has found. In industrialized countries,...

Vaccinators Target 1.4 Million Children in Attempt to Eradicate Disease in Somalia.(polio )
September 27, 2000... 2000 SEP 27 - (NewsRx.com) -- Somalia recorded the last known case of smallpox, and the 6,000 vaccinators who fanned out across the country on September 12, 2000, hope their beleaguered nation will not be the last to eradicate polio as...

In utero DNA Vaccine Delivery Induces Fetal Protective Immunity in Animal Model.
September 27, 2000... 2000 SEP 27 - (NewsRx.com) -- Members of the Veterinary Infectious Disease Organization (VIDO) reported that fetal immunization by a DNA vaccine delivered into the amniotic fluid may be a way of reducing vertical transmission of...